强生 JNJ 深 沪
已收盘 08-07 16:00:00 美东时间
259.24
+2.260
+0.88%
华盛通- 最 高259.60
- 今 开255.89
- 成交量 653.20万股
- 最 低 255.12
- 昨 收 256.98
- 总市值 6247.42亿
- 52周最高 274.90
- 市盈率 静 23.50
- 换手率 0.27%
- 52周最低 169.39
- 委 比 -12.68%
- 总股本 24.10亿
- 历史最高 274.90
- 量 比 0.92
- 振 幅 1.74%
- 历史最低 10.04
- 每 手 1
- 风险率 28.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多根据美国证券交易委员会（SEC）文件披露：强生董事长兼首席执行官华金·杜阿托于8月5日公开市场出售41,957股强生股票，成交平均价格为每股258.056美元。
根据美国证券交易委员会（SEC）文件披露：强生董事长兼首席执行官华金·杜阿托于8月5日公开市场出售41,957股强生股票，成交平均价格为每股258.056美元。
今天 05:55
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
抄底成功？散户周三疯狂涌入，SpaceX周四股价强势反弹！
①SpaceX周二发布IPO后首份财报，但其股价在周三跌至108.27美元，创历史新低；②该公司第二季度AI相关资本支出较分析师预期高40%，叠加即将到来的大规模股票解禁是引发大跌的主要原因；③数据显示，周三开盘时，散户逆势大额买入SpaceX，与机构抛售形成反差。
08-06 22:45
Johnson & Johnson (JNJ) Gets a Buy from Citi
Citi analyst Joanne Wuensch maintained a Buy rating on Johnson & Johnson ye...
08-05 16:05
Intuitive Machines selected by L3Harris to supply 18 spacecraft for missile defense
Intuitive Machines Inc. (LUNR) said Tuesday it has been selected by L3Harris Technologies (LHX) to design and manufacture spacecraft platforms for the Space Development Agency's Accelerated Missile De...
08-05 03:26
Johnson & Johnson announces leadership change in Innovative Medicine
Johnson & Johnson ( ($JNJ) ) has provided an announcement. On August 4, 202...
08-04 21:52
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Helus Pharma names ex-Intra-Cellular executive Michael Halstead as CEO
Helus Pharma (HELP) has appointed Michael Halstead as chief executive officer, effective immediately. Halstead previously served as president of Intra-Cellular Therapies, where he helped scale the com...
08-03 19:59
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
CytomX Therapeutics, Inc. has appointed Alejandra Carvajal as its new Chief Legal Officer. With over two decades of legal experience in the biotechnology sector, Carvajal will support the company's strategic and operational initiatives. She previously served as Chief Legal Officer at Mersana Therapeutics and Momenta Pharmaceuticals. CytomX, a clinical-stage oncology-focused biopharmaceutical company, is advancing its PROBODY® therapeutic platform...
08-03 12:00
公司简介
公司名称
|
强生
|
行业分类
|
制药
|
业务描述
|
强生是全球具综合性、业务分布范围广的医疗保健企业，业务涉及消费品、制药、医疗器材三大领域，1985年在华创立了第一家合资企业。强生遵循企业信条的价值观，致力于践行“关爱全世界,关注每个人”的健康愿景，以领先的科技研发创造创新的理念、产品和服务，为改善人类健康和福祉而不懈努力。每天，强生遍布世界各地的员工，与他们的合作方一起，为全球消费者和病患带来更健康、更快乐、更长寿的生活。
|
根据美国证券交易委员会（SEC）文件披露：强生董事长兼首席执行官华金·杜阿托于8月5日公开市场出售41,957股强生股票，成交平均价格为每股258.056美元。
根据美国证券交易委员会（SEC）文件披露：强生董事长兼首席执行官华金·杜阿托于8月5日公开市场出售41,957股强生股票，成交平均价格为每股258.056美元。
今天 05:55
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
抄底成功？散户周三疯狂涌入，SpaceX周四股价强势反弹！
①SpaceX周二发布IPO后首份财报，但其股价在周三跌至108.27美元，创历史新低；②该公司第二季度AI相关资本支出较分析师预期高40%，叠加即将到来的大规模股票解禁是引发大跌的主要原因；③数据显示，周三开盘时，散户逆势大额买入SpaceX，与机构抛售形成反差。
08-06 22:45
Johnson & Johnson (JNJ) Gets a Buy from Citi
Citi analyst Joanne Wuensch maintained a Buy rating on Johnson & Johnson ye...
08-05 16:05
Intuitive Machines selected by L3Harris to supply 18 spacecraft for missile defense
Intuitive Machines Inc. (LUNR) said Tuesday it has been selected by L3Harris Technologies (LHX) to design and manufacture spacecraft platforms for the Space Development Agency's Accelerated Missile De...
08-05 03:26
Johnson & Johnson announces leadership change in Innovative Medicine
Johnson & Johnson ( ($JNJ) ) has provided an announcement. On August 4, 202...
08-04 21:52
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Helus Pharma names ex-Intra-Cellular executive Michael Halstead as CEO
Helus Pharma (HELP) has appointed Michael Halstead as chief executive officer, effective immediately. Halstead previously served as president of Intra-Cellular Therapies, where he helped scale the com...
08-03 19:59
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
CytomX Therapeutics, Inc. has appointed Alejandra Carvajal as its new Chief Legal Officer. With over two decades of legal experience in the biotechnology sector, Carvajal will support the company's strategic and operational initiatives. She previously served as Chief Legal Officer at Mersana Therapeutics and Momenta Pharmaceuticals. CytomX, a clinical-stage oncology-focused biopharmaceutical company, is advancing its PROBODY® therapeutic platform...
08-03 12:00
派息除权日
|
每股总股息
| 派息日期 |
2026-08-25
|
1.34
|
2026-09-08
|
2026-05-26
|
1.34
|
2026-06-09
|
2026-02-24
|
1.30
|
2026-03-10
|
2025-11-25
|
1.30
|
2025-12-09
|
2025-08-26
|
1.30
|
2025-09-09
|
2025-05-27
|
1.30
|
2025-06-10
|
2025-02-18
|
1.24
|
2025-03-04
|
2024-11-26
|
1.24
|
2024-12-10
|
2024-08-27
|
1.24
|
2024-09-10
|
2024-05-20
|
1.24
|
2024-06-04
|
2024-02-16
|
1.19
|
2024-03-05
|
2023-11-20
|
1.19
|
2023-12-05
|
2023-08-25
|
1.19
|
2023-09-07
|
2023-05-22
|
1.19
|
2023-06-06
|
2023-02-17
|
1.13
|
2023-03-07
|
2022-11-21
|
1.13
|
2022-12-06
|
2022-08-22
|
1.13
|
2022-09-06
|
2022-05-23
|
1.13
|
2022-06-07
|
2022-02-18
|
1.06
|
2022-03-08
|
2021-11-22
|
1.06
|
2021-12-07
|
2021-08-23
|
1.06
|
2021-09-07
|
2021-05-24
|
1.06
|
2021-06-08
|
2021-02-22
|
1.01
|
2021-03-09
|
2020-11-23
|
1.01
|
2020-12-08
|
2020-08-24
|
1.01
|
2020-09-08
|
2020-05-22
|
1.01
|
2020-06-09
|
2020-02-24
|
0.95
|
2020-03-10
|
2019-11-25
|
0.95
|
2019-12-10
|
2019-08-26
|
0.95
|
2019-09-10
|
2019-05-24
|
0.95
|
2019-06-11
|
2019-02-25
|
0.90
|
2019-03-12
|
2018-11-26
|
0.90
|
2018-12-11
|
2018-08-27
|
0.90
|
2018-09-11
|
2018-05-25
|
0.90
|
2018-06-12
|
2018-02-26
|
0.84
|
2018-03-13
|
2017-11-27
|
0.84
|
2017-12-12
|
2017-08-25
|
0.84
|
2017-09-12
|
2017-05-25
|
0.84
|
2017-06-13
|
2017-02-24
|
0.80
|
2017-03-14
|
2016-11-18
|
0.80
|
2016-12-06
|
2016-08-19
|
0.80
|
2016-09-06
|
2016-05-20
|
0.80
|
2016-06-07
|
2016-02-19
|
0.75
|
2016-03-08
|
2015-11-20
|
0.75
|
2015-12-08
|
2015-08-21
|
0.75
|
2015-09-08
|
2015-05-21
|
0.75
|
2015-06-09
|
2015-02-20
|
0.70
|
2015-03-10
|
2014-11-21
|
0.70
|
2014-12-09
|
2014-08-22
|
0.70
|
2014-09-09
|
2014-05-22
|
0.70
|
2014-06-10
|
2014-02-21
|
0.66
|
2014-03-11
|
2013-11-22
|
0.66
|
2013-12-10
|
2013-08-23
|
0.66
|
2013-09-10
|
2013-05-23
|
0.66
|
2013-06-11
|
2013-02-22
|
0.61
|
2013-03-12
|
2012-11-23
|
0.61
|
2012-12-11
|
2012-08-24
|
0.61
|
2012-09-11
|
2012-05-24
|
0.61
|
2012-06-12
|
2012-02-24
|
0.57
|
2012-03-13
|
2011-11-25
|
0.57
|
2011-12-13
|
2011-08-26
|
0.57
|
2011-09-13
|
2011-05-26
|
0.57
|
2011-06-14
|
2011-02-25
|
0.54
|
2011-03-15
|
2010-11-26
|
0.54
|
2010-12-14
|
2010-08-27
|
0.54
|
2010-09-14
|
2010-05-27
|
0.54
|
2010-06-15
|
2010-02-19
|
0.49
|
2010-03-09
|
2009-11-20
|
0.49
|
2009-12-08
|
2009-08-21
|
0.49
|
2009-09-08
|
2009-05-21
|
0.49
|
2009-06-09
|
2009-02-20
|
0.46
|
2009-03-10
|
2008-11-21
|
0.46
|
2008-12-09
|
2008-08-22
|
0.46
|
2008-09-09
|
2008-05-22
|
0.46
|
2008-06-10
|
2008-02-22
|
0.41
|
2008-03-11
|
2007-11-23
|
0.41
|
2007-12-11
|
2007-08-24
|
0.41
|
2007-09-11
|
2007-05-24
|
0.41
|
2007-06-12
|
2007-02-23
|
0.38
|
2007-03-13
|
2006-11-24
|
0.38
|
2006-12-12
|
2006-08-25
|
0.38
|
2006-09-12
|
2006-05-25
|
0.38
|
2006-06-13
|
2006-02-24
|
0.33
|
2006-03-14
|
2005-11-18
|
0.33
|
2005-12-13
|
2005-08-19
|
0.33
|
2005-09-13
|
2005-05-13
|
0.33
|
2005-06-07
|
2005-02-11
|
0.28
|
2005-03-08
|
2004-11-12
|
0.28
|
2004-12-07
|
2004-08-13
|
0.28
|
2004-09-07
|
2004-05-14
|
0.28
|
2004-06-08
|
2004-02-12
|
0.24
|
2004-03-09
|
2003-11-14
|
0.24
|
2003-12-09
|
2003-08-15
|
0.24
|
2003-09-09
|
2003-05-16
|
0.24
|
2003-06-10
|
2003-02-13
|
0.20
|
2003-03-11
|
2002-11-15
|
0.20
|
2002-12-10
|
2002-08-16
|
0.20
|
2002-09-10
|
2002-05-17
|
0.20
|
2002-06-11
|
2002-02-14
|
0.18
|
2002-03-12
|
2001-11-16
|
0.18
|
2001-12-11
|
2001-08-17
|
0.18
|
2001-09-11
|
2001-05-18
|
0.36
|
2001-06-12
|
2001-02-15
|
0.32
|
2001-03-13
|
2000-11-17
|
0.32
|
2000-12-12
|
2000-08-18
|
0.32
|
2000-09-12
|
2000-05-19
|
0.32
|
2000-06-13
|
2000-02-11
|
0.28
|
2000-03-07
|
1999-11-12
|
0.28
|
1999-12-07
|
1999-08-13
|
0.28
|
1999-09-07
|
1999-05-14
|
0.28
|
1999-06-08
|
1999-02-11
|
0.25
|
1999-03-09
|
1998-11-13
|
0.25
|
1998-12-08
|
1998-08-14
|
0.25
|
1998-09-08
|
1998-05-15
|
0.25
|
1998-06-09
|
1998-02-12
|
0.22
|
1998-03-10
|
1997-11-14
|
0.22
|
1997-12-09
|
1997-08-15
|
0.22
|
1997-09-09
|
1997-05-16
|
0.22
|
1997-06-10
|
1997-02-13
|
0.19
|
1997-03-11
|
1996-11-15
|
0.19
|
1996-12-10
|
1996-08-16
|
0.19
|
1996-09-10
|
1996-05-17
|
0.38
|
1996-06-11
|
1996-02-15
|
0.33
|
1996-03-12
|
1995-11-10
|
0.33
|
1995-12-05
|
1995-08-11
|
0.33
|
1995-09-05
|
1995-05-10
|
0.33
|
1995-06-06
|
1995-02-08
|
0.29
|
1995-03-07
|
1994-11-08
|
0.29
|
1994-12-06
|
1994-08-10
|
0.29
|
1994-09-06
|
1994-05-11
|
0.29
|
1994-06-07
|
1994-02-09
|
0.26
|
1994-03-08
|
1993-11-09
|
0.26
|
1993-12-07
|
1993-08-11
|
0.26
|
1993-09-07
|
1993-05-12
|
0.26
|
1993-06-08
|
1993-02-09
|
0.23
|
1993-03-09
|
1992-11-10
|
0.23
|
1992-12-08
|
1992-08-12
|
0.23
|
1992-09-08
|
1992-05-13
|
0.46
|
1992-06-09
|
1992-02-11
|
0.40
|
1992-03-10
|
1991-11-13
|
0.40
|
1991-12-10
|
1991-08-14
|
0.40
|
1991-09-10
|
1991-05-15
|
0.40
|
1991-06-11
|
1991-02-12
|
0.34
|
1991-03-12
|
1990-11-14
|
0.34
|
1990-12-04
|
1990-08-15
|
0.34
|
1990-09-04
|
1990-05-16
|
0.34
|
1990-06-05
|
1990-02-13
|
0.29
|
1990-03-06
|
1989-11-15
|
0.29
|
1989-12-05
|
1989-08-16
|
0.29
|
1989-09-05
|
1989-05-22
|
0.29
|
1989-06-06
|
1989-02-14
|
0.50
|
1989-03-07
|
1988-11-16
|
0.50
|
1988-12-06
|
1988-08-17
|
0.50
|
1988-09-06
|
1988-05-18
|
0.50
|
1988-06-07
|
1988-02-17
|
0.42
|
1988-03-08
|
1987-11-16
|
0.42
|
1987-12-10
|
1987-08-17
|
0.42
|
1987-09-10
|
1987-05-22
|
0.42
|
1987-06-11
|
1987-02-23
|
0.35
|
1987-03-12
|
1986-11-17
|
0.35
|
1986-12-11
|
1986-08-18
|
0.35
|
1986-09-11
|
1986-05-23
|
0.35
|
1986-06-12
|
1986-02-04
|
0.32
|
1986-03-13
|
1985-11-18
|
0.32
|
1985-12-12
|
1985-08-19
|
0.32
|
1985-09-12
|
1985-05-24
|
0.32
|
1985-06-13
|
1985-02-15
|
0.30
|
1985-03-14
|
1984-11-16
|
0.30
|
1984-12-13
|
1984-08-20
|
0.30
|
1984-09-13
|
1984-05-21
|
0.30
|
1984-06-14
|
1984-02-17
|
0.28
|
1984-03-08
|
1983-11-14
|
0.28
|
1983-12-08
|
1983-08-15
|
0.28
|
1983-09-08
|
1983-05-16
|
0.28
|
1983-06-09
|
1983-02-18
|
0.25
|
1983-03-10
|
1982-11-15
|
0.25
|
1982-12-09
|
1982-08-16
|
0.25
|
1982-09-09
|
1982-05-17
|
0.25
|
1982-06-10
|
1982-02-22
|
0.22
|
1982-03-11
|
1981-11-16
|
0.22
|
1981-12-10
|
1981-08-17
|
0.22
|
1981-09-10
|
1981-05-22
|
0.22
|
1981-06-11
|
1981-02-13
|
0.57
|
1981-03-11
|
1980-11-17
|
0.57
|
1980-12-11
|
1980-08-18
|
0.57
|
1980-09-11
|
1980-05-19
|
0.57
|
1980-06-11
|
1980-02-14
|
0.50
|
1980-03-10
|
1979-11-15
|
0.50
|
1979-12-11
|
1979-08-19
|
0.50
|
1979-09-11
|
1979-05-20
|
0.50
|
1979-06-11
|
1979-02-19
|
0.50
|
1979-03-11
|
1978-11-12
|
0.43
|
1978-12-07
|
1978-08-13
|
0.43
|
1978-09-07
|
1978-05-14
|
0.43
|
1978-06-07
|
1978-02-09
|
0.43
|
1978-03-07
|
1977-11-13
|
0.35
|
1977-12-08
|
1977-08-14
|
0.35
|
1977-09-08
|
1977-05-15
|
0.35
|
1977-06-08
|
1977-02-17
|
0.25
|
1977-03-08
|
